⌘K

Login Start Free

Home/Filings/4/A/0001209191-23-011127

4/A//SEC Filing

White Ted 4/A

Accession 0001209191-23-011127

CIK 0001660334other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:08 PM ET

Size

4.9 KB

Accession

0001209191-23-011127

Insider Transaction Report

Form 4/AAmended

Period: 2022-07-05

Verrica Pharmaceuticals Inc.VRCA

DirectorPRESIDENT AND CEO

Transactions

Purchase
Common Stock
2022-07-05$2.10/sh+7,500$15,750→ 29,466 total

Footnotes (1)

[F1]The original Form 4 inadvertently listed the incorrect number of shares purchased by the Reporting Person. This represents the correct number of shares.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

Verrica Pharmaceuticals Inc.

CIK 0001660334

Entity typeother

Related Parties

1

filerCIK 0001741964

Filing Metadata

Form type: 4/A
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 4:08 PM ET
Size: 4.9 KB

View on SEC.gov